» Articles » PMID: 31226245

Characterization of the Interaction of the Antifungal and Cytotoxic Cyclic Glycolipopeptide Hassallidin with Sterol-containing Lipid Membranes

Overview
Publisher Elsevier
Date 2019 Jun 22
PMID 31226245
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Hassallidins are cyclic glycolipopeptides produced by cyanobacteria and other prokaryotes. The hassallidin structure consists of a peptide ring of eight amino acids where a fatty acid chain, additional amino acids, and sugar moieties are attached. Hassallidins show antifungal activity against several opportunistic human pathogenic fungi, but does not harbor antibacterial effects. However, they have not been studied on mammalian cells, and the mechanism of action is unknown. We purified hassallidin D from cultured cyanobacterium Anabaena sp. UHCC 0258 and characterized its effect on mammalian and fungal cells. Ultrastructural analysis showed that hassallidin D disrupts cell membranes, causing a lytic/necrotic cell death with rapid presence of disintegrated outer membrane, accompanied by internalization of small molecules such as propidium iodide into the cells. Furthermore, artificial liposomal membrane assay showed that hassallidin D selectively targets sterol-containing membranes. Finally, in silico membrane modeling allowed us to study the interaction between hassallidin D and membranes in detail, and confirm the role of cholesterol for hassallidin-insertion into the membrane. This study demonstrates the mechanism of action of the natural compound hassallidin, and gives further insight into how bioactive lipopeptide metabolites selectively target eukaryotic cell membranes.

Citing Articles

Algae and Cyanobacteria Fatty Acids and Bioactive Metabolites: Natural Antifungal Alternative Against sp.

Lopez-Arellanes M, Lopez-Pacheco L, Elizondo-Luevano J, Gonzalez-Meza G Microorganisms. 2025; 13(2).

PMID: 40005804 PMC: 11858688. DOI: 10.3390/microorganisms13020439.


Marine Bioactive Peptides: Anti-Photoaging Mechanisms and Potential Skin Protective Effects.

Zhang X, Zhuang H, Wu S, Mao C, Dai Y, Yan H Curr Issues Mol Biol. 2024; 46(2):990-1009.

PMID: 38392181 PMC: 10887644. DOI: 10.3390/cimb46020063.


Nanoparticles assisted intra and transdermic delivery of antifungal ointment: an updated review.

Tarannum N, Pooja K, Jakhar S, Mavi A Discov Nano. 2024; 19(1):11.

PMID: 38195832 PMC: 10776542. DOI: 10.1186/s11671-023-03932-3.


Cyanobacteria: A Promising Source of Antifungal Metabolites.

do Amaral S, Xavier L, Vasconcelos V, Santos A Mar Drugs. 2023; 21(6).

PMID: 37367684 PMC: 10300848. DOI: 10.3390/md21060359.


Glycosylation and Lipidation Strategies: Approaches for Improving Antimicrobial Peptide Efficacy.

Bellavita R, Braccia S, Galdiero S, Falanga A Pharmaceuticals (Basel). 2023; 16(3).

PMID: 36986538 PMC: 10059750. DOI: 10.3390/ph16030439.